Protalix BioTherapeutics Company
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Investors
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Carmiel, HaZafon, Israel
Founded Date:
1994
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
1
Total Funding:
$10.8M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Seed
Register and Claim Ownership